4//SEC Filing
Jenne Kyle 4
Accession 0000874015-24-000133
CIK 0000874015other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:52 PM ET
Size
5.7 KB
Accession
0000874015-24-000133
Insider Transaction Report
Form 4
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-02-26+65,203→ 65,203 totalExercise: $46.10From: 2025-02-26Exp: 2034-02-25→ Common Stock (65,203 underlying)
Footnotes (1)
- [F1]Grant on 02/26/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 02/26/2024. 25% of the shares subject to the option will vest and become exercisable on 02/26/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001791857
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:52 PM ET
- Size
- 5.7 KB